Literature DB >> 9861051

Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

Y Coulouarn1, I Lihrmann, S Jegou, Y Anouar, H Tostivint, J C Beauvillain, J M Conlon, H A Bern, H Vaudry.   

Abstract

Urotensin II (UII) is a cyclic peptide initially isolated from the caudal neurosecretory system of teleost fish. Subsequently, UII has been characterized from a frog brain extract, indicating that a gene encoding a UII precursor is also present in the genome of a tetrapod. Here, we report the characterization of the cDNAs encoding frog and human UII precursors and the localization of the corresponding mRNAs. In both frog and human, the UII sequence is located at the C-terminal position of the precursor. Human UII is composed of only 11 amino acid residues, while fish and frog UII possess 12 and 13 amino acid residues, respectively. The cyclic region of UII, which is responsible for the biological activity of the peptide, has been fully conserved from fish to human. Northern blot and dot blot analysis revealed that UII precursor mRNAs are found predominantly in the frog and human spinal cord. In situ hybridization studies showed that the UII precursor gene is actively expressed in motoneurons. The present study demonstrates that UII, which has long been regarded as a peptide exclusively produced by the urophysis of teleost fish, is actually present in the brain of amphibians and mammals. The fact that evolutionary pressure has acted to conserve fully the biologically active sequence of UII suggests that the peptide may exert important physiological functions in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861051      PMCID: PMC28125          DOI: 10.1073/pnas.95.26.15803

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin.

Authors:  L de Lecea; P Ruiz-Lozano; P E Danielson; J Peelle-Kirley; P E Foye; W N Frankel; J G Sutcliffe
Journal:  Genomics       Date:  1997-06-15       Impact factor: 5.736

2.  Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides.

Authors:  H Tostivint; I Lihrmann; C Bucharles; D Vieau; Y Coulouarn; A Fournier; J M Conlon; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization.

Authors:  N Chartrel; J M Conlon; F Collin; B Braun; D Waugh; M Vallarino; S L Lahrichi; J E Rivier; H Vaudry
Journal:  J Comp Neurol       Date:  1996-01-08       Impact factor: 3.215

Review 4.  The peptidergic motoneurone.

Authors:  U Arvidsson; F Piehl; H Johnson; B Ulfhake; S Cullheim; T Hökfelt
Journal:  Neuroreport       Date:  1993-07       Impact factor: 1.837

5.  The structure of cloned DNA complementary to catfish pancreatic somatostatin-14 messenger RNA.

Authors:  C D Minth; W L Taylor; M Magazin; M A Tavianini; K Collier; H L Weith; J E Dixon
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

6.  Primary structures of multiple forms of urotensin II in the urophysis of the carp, Cyprinus carpio.

Authors:  T Ichikawa; K Lederis; H Kobayashi
Journal:  Gen Comp Endocrinol       Date:  1984-07       Impact factor: 2.822

7.  Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

Authors:  D Pearson; J E Shively; B R Clark; I I Geschwind; M Barkley; R S Nishioka; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

8.  Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda.

Authors:  J M Conlon; F O'Harte; D D Smith; M C Tonon; H Vaudry
Journal:  Biochem Biophys Res Commun       Date:  1992-10-30       Impact factor: 3.575

9.  Cloning and characterization of human urocortin.

Authors:  C J Donaldson; S W Sutton; M H Perrin; A Z Corrigan; K A Lewis; J E Rivier; J M Vaughan; W W Vale
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

10.  Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions.

Authors:  C Sala; J S Andreose; G Fumagalli; T Lømo
Journal:  J Neurosci       Date:  1995-01       Impact factor: 6.167

View more
  70 in total

1.  Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.

Authors:  S A Douglas; A C Sulpizio; V Piercy; H M Sarau; R S Ames; N V Aiyar; E H Ohlstein; R N Willette
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.

Authors:  Ying-Ying Li; Zheng-Ming Shi; Xiao-Yong Yu; Ping Feng; Xue-Jiang Wang
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Dynamic expression pattern of corticotropin-releasing hormone, urotensin I and II genes under acute salinity and temperature challenge during early development of zebrafish.

Authors:  Lei Luo; Aqin Chen; Chongchong Hu; Weiqun Lu
Journal:  Fish Physiol Biochem       Date:  2014-08-26       Impact factor: 2.794

4.  Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling.

Authors:  Ana Patrícia Fontes-Sousa; Carmen Brás-Silva; Ana Luísa Pires; Daniela Monteiro-Sousa; Adelino F Leite-Moreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-14       Impact factor: 3.000

5.  Cardiostimulant effects of urotensin-II in human heart in vitro.

Authors:  F D Russell; P Molenaar; D M O'Brien
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  A new ligand for the urotensin II receptor.

Authors:  Valeria Camarda; Remo Guerrini; Evi Kostenis; Anna Rizzi; Girolamo Calò; Almut Hattenberger; Marina Zucchini; Severo Salvadori; Domenico Regoli
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.

Authors:  Z Wenyi; S Suzuki; M Hirai; Y Hinokio; Y Tanizawa; A Matsutani; J Satoh; Y Oka
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

8.  Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice.

Authors:  Cheng-Hua Zhou; Ya-Ya Wan; Xiang-Hua Chu; Zheng Song; Shu-Hua Xing; Yu-Qing Wu; Xiao-Xing Yin
Journal:  Oncol Lett       Date:  2012-09-21       Impact factor: 2.967

9.  Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity.

Authors:  Nicolas Chartrel; Cynthia Dujardin; Youssef Anouar; Jérôme Leprince; Annick Decker; Stefan Clerens; Jean-Claude Do-Régo; Frans Vandesande; Catherine Llorens-Cortes; Jean Costentin; Jean-Claude Beauvillain; Hubert Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Vasoconstrictive effects of endothelin-1, endothelin-3, and urotensin II in isolated perfused human lungs and isolated human pulmonary arteries.

Authors:  R T Bennett; R D Jones; A H Morice; C F C Smith; M E Cowen
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.